Looking for Income

What neurotoxicities are associated with T-cell therapies? How are these toxicities managed? What is the risk of delayed toxicity?
What follow-up appointments should be necessary before and after treatment?
Why is chromosome 14 a site of high-risk myeloma genetics?
What is the difference between light chain myeloma and amyloidosis?
Fixed duration therapy vs. continuous duration therapy for CLL patients
Why is it important for a myeloma patient to be aware of the symptoms of amyloidosis?